Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 1/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.44 |
| ▸ | RARB | P10826 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.42 |
| ▸ | AHR | P35869 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30745239 | 1.00 | SYK (0.46) | SYKCYP11B1CYP11B2RARBCYP3A4 | |
| SCHEMBL20928535 | 0.97 | SYK (0.46) | SYKCYP11B1CYP11B2RARBCYP3A4 | |
| SCHEMBL30504169 | 0.97 | SYK (0.46) | SYKCYP11B1CYP11B2RARBCYP3A4 | |
| SCHEMBL30504175 | 0.96 | SYK (0.45) | SYKCYP11B1CYP11B2RARBCYP3A4 | |
| SCHEMBL30504178 | 0.96 | SYK (0.45) | SYKCYP11B1CYP11B2RARBCYP3A4 | |
| SCHEMBL20928525 | 0.96 | SYK (0.45) | SYKCYP11B1CYP11B2RARBCYP3A4 | |
| SCHEMBL20928526 | 0.96 | SYK (0.45) | SYKCYP11B1CYP11B2RARBCYP3A4 | |
| SCHEMBL20928544 | 0.95 | SYK (0.46) | SYKCYP11B1CYP11B2RARBCYP3A4 | |
| SCHEMBL30504170 | 0.95 | SYK (0.46) | SYKCYP11B1CYP11B2RARBCYP3A4 | |
| SCHEMBL20928533 | 0.93 | PTPN11 (0.47) | RARBCYP3A4CYP2D6PTPN11NR5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11891558-B2 | Solid foam comprising mesogenic ligand-functionalized nanoparticles and methods of making and using the same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-02-06 | — | — | US | disclosed |
| US-11708530-B2 | Organic ligands for templatable mesoscale nanocapsules | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-07-25 | — | — | US | disclosed |
| US-11708530-B2 | Organic ligands for templatable mesoscale nanocapsules | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-07-25 | — | — | US | disclosed |
| US-20210179939-A1 | Organic Ligands For Templatable Mesoscale Nanocapsules | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2021-06-17 | — | — | US | disclosed |
| US-20200239781-A1 | Solid Foam Comprising Mesogenic Ligand-Functionalized Nanoparticles and Methods of Making and Using the Same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-07-30 | — | — | US | disclosed |
| US-20200239781-A1 | Solid Foam Comprising Mesogenic Ligand-Functionalized Nanoparticles and Methods of Making and Using the Same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-07-30 | — | — | US | disclosed |
| WO-2019079507-A1 | SOLID FOAM COMPRISING MESOGENIC LIGAND-FUNCTIONALIZED NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-04-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210179939-A1 | Organic Ligands For Templatable Mesoscale Nanocapsules | EPCAM, L1CAM, ICOSLG | SYK 1626/4885CYP11B1 4696/4885CYP11B2 4685/4885 |
| US-11708530-B2 | Organic ligands for templatable mesoscale nanocapsules | EPCAM, L1CAM, ICOSLG | SYK 1626/4885CYP11B1 4696/4885CYP11B2 4685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.